NCT04873999

Brief Summary

This observational PMCF study will be conducted to generate and gather clinical data from the intended target population of pediatric patients. The intention for Post-Market Clinical Follow-up (PMCF) is to confirm the performance and safety of a device throughout the device's lifecycle. PulmoVista 500 is a lung function monitor for clinical use which continuously generates cross-sectional images of the lung function by applying the technique of electrical impedance tomography (EIT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

May 3, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2021

Completed
Last Updated

March 29, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

April 30, 2021

Last Update Submit

March 28, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • assess the capability of PulmoVista 500 for continuous monitoring of ventilation

    To assess the capability of PulmoVista 500 for continuous monitoring of ventilation, the cross-correlation function (CCF) between the global impedance waveform of EIT and global tidal volume waveforms of a ventilator across multiple respiratory cycles in patients under controlled mechanical ventilation, will be evaluated.

    Duration per participant: 2 - 3 days (screening, procedure with PulmoVista 500, safety follow-up). Measurements with PulmoVista 500 per patient during mechanical ventilation is anticipated for a maximum of 10 minutes in total.

Eligibility Criteria

AgeUp to 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients that visit the hospital for any kind of surgery, therefore requireing mechanical ventilation. Monitoring of Regional Distribution of Ventilation and Lung Volume are of clinical interest in these patients.

You may qualify if:

  • Pediatric male or female patients excluding preterm infants
  • Patients with a chest circumference between 36 and 72 cm
  • Patients ≤ 12 years.
  • Patients with a tidal volume \> 20 ml, i.e., children with a body weight of more than 3.3 kg (assuming a targeted tidal volume of 6 mL/kg body weight)
  • Patients for whom mechanical ventilation is intended
  • Patients whose regional distribution of ventilation and of lung volume are of clinical interest
  • Patients who are (should be) ventilated via an artificial airway access, whereby the ventilator used is compatible with PulmoVista 500
  • Patients and / or their legal guardians or legal representatives who have given written informed consent to participate in the study

You may not qualify if:

  • Patients who are supplied with a permanent or temporary pacemaker, an implantable defibrillator or other medical devices that emit electrical energy (e.g. cochlea amplifier implant)
  • Patients with a tidal volume ≤ 20 ml
  • Patients in whom the application of the electrode belt could be impaired by wound care or infections in the chest area
  • Female patients for whom pregnancy cannot be excluded; a pregnancy test should be performed at the discretion of the investigator.
  • Patients with an alleged allergic reaction to the materials of the electrode belt
  • Patients with a Body Mass Index (BMI) \> 40
  • Evidence that suggests that the patient or their legal representative will not comply with the protocol requirements
  • Patients with a proven infectious disease (e.g. SARS-COV-19, MRSA) that requires isolation of the patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik für Kinder- und Jugendmedizin Klinikum Traunstein

Traunstein, 83278, Germany

Location

Related Publications (1)

  • Clasen D, Winter I, Rietzler S, Wolf GK. Changes in ventilation distribution during general anesthesia measured with EIT in mechanically ventilated small children. BMC Anesthesiol. 2023 Apr 12;23(1):118. doi: 10.1186/s12871-023-02079-z.

Study Officials

  • Gerhard Wolf, PD Dr.

    Children's hospital Traunstein

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 5, 2021

Study Start

May 3, 2021

Primary Completion

July 28, 2021

Study Completion

July 28, 2021

Last Updated

March 29, 2022

Record last verified: 2022-03

Locations